Develops capsule endoscopes for small bowel diseases.
Jun 2026Revenue $13.9M/yrExpenses $44.0M/yr
No trend
Figures by year
When will CapsoVision be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $13.9M and expenses $44.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $13.6M | $39.1M | −$25.5M |
| Dec 2024 | $11.8M | $31.7M | −$19.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.